The Acusera Smart controls range is designed to fit directly onto a wide range of test systems
without the need to aliquot material, streamlining the QC process by minimising human error
and optimising workflow.
The Acusera Smart Liquid Cardiac Control is designed to cover a range of cardiac markers at clinical decision levels, eliminating the need for additional low-level controls at extra expenses. It is intended for use with in vitrodiagnostic assays for the quantitative determination of 7 cardiac markers. This control also has an impressive 14 day open vial stability for Troponin I, and 30 days for other analytes. It is designed for use in the routine monitoring of both accuracy and precision.
Analytes:
• CK-MB
• Homocysteine
• hsCRP
• Myoglobin
• Troponin I
• Digoxin
• NT-proBNP
Benefits:
• Liquid frozen
• Human serum based
• Open vial stability of 30 days at 2-8ºC for most analytes (excluding Troponin I)
• Consolidates 7 key cardiac markers
• Cut off levels for Troponin I in line with internationally recommended levels